<?xml version="1.0" encoding="UTF-8"?>
<ref id="ppat.1007760.ref031">
 <label>31</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Tijsma</surname>
   <given-names>A</given-names>
  </name>, 
  <name>
   <surname>Franco</surname>
   <given-names>D</given-names>
  </name>, 
  <name>
   <surname>Tucker</surname>
   <given-names>S</given-names>
  </name>, 
  <name>
   <surname>Hilgenfeld</surname>
   <given-names>R</given-names>
  </name>, 
  <name>
   <surname>Froeyen</surname>
   <given-names>M</given-names>
  </name>, 
  <name>
   <surname>Leyssen</surname>
   <given-names>P</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>The capsid binder vapendavir and the novel protease inhibitor SG85 inhibit enterovirus 71 replication</article-title>. 
  <source>Antimicrob Agents Chemother</source>. 
  <year>2014</year>;
  <volume>58</volume>: 
  <fpage>6990</fpage>â€“
  <lpage>6992</lpage>. 
  <pub-id pub-id-type="doi">10.1128/AAC.03328-14</pub-id>
  <?supplied-pmid 25199773?>
  <pub-id pub-id-type="pmid">25199773</pub-id>
 </mixed-citation>
</ref>
